Touro La-Ld Oral Tablet, Extended Release 525-50Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Touro LA-LD: Oral tablet, extended release (525-50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_10086.JPG
Entex PSE 50mg-525mg SR Tab
Athlon Pharmaceuticals Inc
Pill Identification: P525 

In-Depth Information

Touro LA-LD 525mg-50mg Extended-Release Tablet

NDC: 588690635
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




FDA approved for the following conditions:
Cough, Allergic Rhinitis, Common Cold, Nasal Congestion

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Touro LA-LD 525mg-50mg Extended-Release Tablet
Daily Life Interactions for Touro LA-LD 525mg-50mg Extended-Release Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Caffeine-containing Foods/Beverages and Touro LA-LD 525mg-50mg Extended-Release Tablet(Pseudoephedrine Hydrochloride)
Caffeine-containing Foods/Beverages and Pseudoephedrine(Pseudoephedrine Hydrochloride)
Limit caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) while taking Pseudoephedrine. Also avoid medicines containing additional Caffeine whenever possible. Side effects from Pseudoephedrine may get worse if you take excessive Caffeine. Taking a high amount of Caffeine can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, tremor, or other side effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Touro LA-LD

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5